组内动态-en – 卢敏课题组

The Min Lu Research Group

Shanghai Institute of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

State Key Laboratory of Omics and Disease (formerly State Key Laboratory of Medical Genomics)

The Min Lu Research Group

Shanghai Institute of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

State Key Laboratory of Omics and Disease (formerly State Key Laboratory of Medical Genomics)

Team members participate in team building and leisure activities in Songjiang, Shanghai

2025年5月16日

生活时光

2025年5月16日

The members of the research team celebrated the birthday of team member Wu Jiaqi together in the laboratory

2025年5月16日

The research achievement of the research group that arsenic trioxide restores the anti-cancer function of p53 structural mutant has been interpreted in a long article in Cancer Cell

2025年5月16日

The research results of the research group on arsenic trioxide restoring the anti-cancer function of p53 structural mutant were published online in Cancer Cell on December 26, 2020, which has caused a great response in both academic and industrial circles at home and abroad

2025年5月16日

Dr. Chen Xueqin from the research group successfully completed his graduation defense and became a postdoctoral fellow in the research group

2025年5月12日

Team members and member Song Huaxin celebrate their birthdays together

2024年9月30日

《World Science》 – Cancer occurrence and targeted therapy

2024年7月18日

《Soothing Companionship 》— Is Cancer Really Hereditary?

2024年7月18日

Researcher Lu Min and Dr. Xiao Shujun share the latest research results of Cancer Cell with the Research Society

2024年4月28日

https://mp.weixin.qq.com/s/-4gieARPTsrnQFF06-noyg

搜索你想要的内容

最新动态

The research team carried out team-building activities in 2025 focusing on “alleviating scientific research pressure and stimulating innovative thinking”

2025年5月27日

In 2024, Song Huaxin obtained the project supported by NSFC for Young Scientists

2025年5月27日

The clinical research standards for P53 restorer proposed by the research group in 2025 were published in Nat Rev Cancer

2025年5月27日

Research Direction 1: “From 0 to 1” Targeted Anticancer Protein

2025年5月23日

Research direction-2: drugging ‘smooth’ proteins without druggable pockets

2025年5月21日

Members of the research team had a party and dinner at Meilan Lake, Shanghai

2025年5月17日

联系我们

The Min Lu Research Group

Shanghai Institute of Hematology, Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine

State Key Laboratory of Omics and Disease (formerly State Key Laboratory of Medical Genomics)

The Min Lu Research Group©️Copyright